Sino-Singapore Group/
24.06.2024 8:10:42 | Изменение -0.45 | Объем сделки | Бид24.06.2024 | Предложение24.06.2024 | Максимум | Минимум |
---|---|---|---|---|---|---|
7.42CNY | -5.72% | 6.05 млн Оборот: 44.69 млн |
7.42Величина цены спроса: 300 | 7.43Величина цены предложения: 6,500 | 7.63 | 7.26 |
GlobeNewswire
8:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
7:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
GlobeNewswire
6:20
China's Hangzhou empowers urban development with world-class power supply reliability
GlobeNewswire
3:00
SALESFORCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Salesforce, Inc. on Behalf of Salesfo...
GlobeNewswire
3:00
NIKE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница